Skip to content

Sarah Mcnamee

2 papers in the library · 167 citations · publishing 2023-2025

Papers

Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape

JAMA Psychiatry March 29, 2023 Sarah Mcnamee, Neşe Devenot, Meaghan Buisson 167 citations

Serious adverse events in psychedelic-assisted therapy trials can arise from interactions between therapists and patients. This Viewpoint discusses such events, highlighting the importance of therapeutic relationship dynamics in ensuring participant safety.

The code less travelled: Can the Canadian Psychological Association code of ethics support ethical decision making in the new era of psychedelic-assisted psychotherapy?

Canadian Psychology / Psychologie canadienne October 20, 2025 Sarah Mcnamee, David Nickles, Lily Kay Ross et al.

The Canadian Psychological Association Code of Ethics provides a framework that can support ethical decision-making in psychedelic-assisted psychotherapy, but its application requires careful consideration of unique challenges such as managing altered states of consciousness, ensuring informed consent, and addressing boundary issues. The code's principles of respect for dignity, responsible caring, integrity, and social responsibility offer guidance, yet the novel therapeutic context demands additional ethical reflection and potential adaptations to maintain professional standards.